In addition, the results showed that LY294002 could not completely abrogate the oncogenic effect of RPL22L1 on PCa, indicating that RPL22L1 may promote PCa progression through other mechanisms besides the PI3K/Akt/mTOR signalling pathway. Here, MTOR is linked to posterior cortical atrophy.